Moderna MRNA 深 沪
等待开盘 11-29 09:30:00 美东时间
25.98
+0.970
+3.88%
华盛通- 最 高26.045
- 今 开25.01
- 成交量 418.60万股
- 最 低 24.87
- 昨 收 25.01
- 总市值 101.58亿
- 52周最高 48.92
- 市盈率 静 --
- 换手率 1.07%
- 52周最低 22.28
- 委 比 -21.99%
- 总股本 3.91亿
- 历史最高 497.49
- 量 比 0.70
- 振 幅 4.70%
- 历史最低 11.54
- 每 手 1
- 风险率 5.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多夜读 | 近20年跑赢巴菲特！基金巨头柏基投资万亿持仓披露，遍地10倍股，三季度买入阿里，建仓Coinbase
近20年跑赢巴菲特！基金巨头柏基投资万亿持仓披露，遍地10倍股，三季度买入阿里，建仓Coinbase>>
11-26 23:35
合同价值超过7亿美元！科兴与巴西卫生部达成十年疫苗合作，创下中国疫苗最大金额国际订单【附疫苗行业市场分析】
（图片来源：摄图网） 据SINOVAC科兴官微消息，当地时间11月24日，科兴与巴西卫生部签署两项PDP(产品开发伙伴关系)项目协议，成为首个中标该项目的中国...
11-26 15:52
AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?
While most eyes are on tech and chipmakers, biotech is quietly staging its biggest rally in over two decades.
11-26 04:14
Vaccine critic selected as CDC deputy director
Ralph Abraham, Louisiana's surgeon general, is the CDC's next deputy director. The Washington Post, which broke the development, noted it is unclear if Abraham has begun his tenure or when he will beg...
11-26 03:21
CytomX Therapeutics to Present at Upcoming December Investor Conferences
CytomX Therapeutics announced that its management will participate in two investor conferences in December 2025: the 8th Annual Evercore Healthcare Conference on December 2 in Coral Gables, FL, and the Piper Sandler 37th Annual Healthcare Conference on December 4 in New York, NY. Both events will feature fireside chats and live webcasts available on CytomX’s website. The company, focused on developing conditionally activated biologics for oncolog...
11-25 13:00
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
11-24 11:23
First-Ever Human H5N5 Case Turns Fatal In Washington State
Washington reports world's first fatal human H5N5 bird flu case; officials say risk to public remains low, monitoring continues closely.
11-23 02:07
Pfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.
11-21 23:48
Why New Fortress Energy (NFE) Shares Jumped Over 20% In After-Hours Trading?
New Fortress Energy shares surged over 20% in after-hours trading on Thursday following a credit facility amendment, but the company faces default risks and a Fitch downgrade.
11-21 11:29
What's Going On With Moderna Stock?
Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business strategy.
11-21 01:41
